Melexis (MELE) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
29 Apr, 2026Executive summary
Q1 2026 sales reached EUR 202.1 million, up 2% year-over-year, with automotive applications accounting for 89% of total sales and gross margin at 39.9%.
Profitability improved due to operational enhancements and cost control, though net profit declined 6% year-over-year to EUR 23.1 million (EPS EUR 0.57).
Strategic progress included expansion in China with a wholly foreign-owned enterprise and new product launches in automotive, robotics, and data centers.
Notable advancements in robotics, including a partnership with OYMotion to integrate Tactaxis technology into robotic hands.
Operating cash flow before working capital changes was EUR 43.8 million, up 1% year-over-year.
Financial highlights
Gross profit margin was 39.9%, up from 38.2% in Q1 2025; EBIT rose 14% year-over-year to EUR 33.2 million (16.4% of sales).
Net result was EUR 23.1 million, down 6% year-over-year but up 2% sequentially; EPS at EUR 0.57.
Free cash flow for Q1 2026 was EUR 82 million.
Net debt stood at EUR 207.0 million at quarter-end.
EUR/USD exchange rate had a 4% negative impact on sales year-over-year.
Outlook and guidance
Sales for H1 2026 expected to be flat year-over-year; H2 2026 sales projected to grow sequentially.
Gross profit margin for H1 2026 expected around 40%, operating margin around 17%.
Full-year 2026 CapEx expected to be around EUR 40 million.
Latest events from Melexis
- 2025 sales fell 10%, profit 34%, but Q4 rebounded; 2026 H2 growth and EUR 3.70/share dividend expected.MELE
Q4 202513 Apr 2026 - Accelerated innovation, market expansion, and robust financial targets drive future growth.MELE
CMD 20253 Feb 2026 - Q2 2024 sales up 4% year-over-year, with strong margins and lower CAPEX guidance.MELE
Q2 20242 Feb 2026 - Q3 sales steady at €247.9M, but full-year outlook cut amid inventory and market headwinds.MELE
Q3 202417 Jan 2026 - Q1 2025 sales dropped 18% year-over-year, with margins pressured and China strategy advancing.MELE
Q1 202524 Dec 2025 - 2024 sales and profits declined, but innovation and design wins support a mid-2025 recovery.MELE
Q4 202416 Dec 2025 - Q3 sales reached €215.3M, down 13% year-over-year, with gross margin at 38.8%.MELE
Q3 202529 Oct 2025 - Sequential sales and margin growth in Q2 2025, with full-year outlook reaffirmed.MELE
Q2 202530 Jul 2025